The biosimilars for the blockbuster drug Humira® will hit the market in 2023. Join our team as we discuss the complexities surrounding biosimilars, how they may influence the pharmacy landscape […]
Increasingly, employer groups have expressed interest in establishing on-site health centers and other supplemental benefit programs as options for their employees. Employers cite the need to help control costs under […]
Under Federal law, group health plans are responsible for various new reporting and disclosure requirements that aim to improve transparency within the healthcare industry. This webinar will review the key […]
Please join us for a robust discussion addressing important issues and trends involving Social Engineering and what can be done to minimize your risk. Three industry veterans will address and […]
Most employers offer their employees healthcare options that include account-based plans—Health FSAs, HRAs or HSAs. According to the International Foundation of Employee Benefits (IFEBP) 2022 Employee Benefits Survey, nearly 70% of private employers and 56% of public employers offer employees one or more highdeductible health plan options paired with a Health Savings Account. Additionally, 10% […]
Please join us for a robust discussion addressing important issues and trends in the Workers' Compensation marketplace. Three industry veterans will address and discuss Return to Work Programs and their importance. They will focus on the necessary elements of a robust program, the interaction between the employee, the Vocational Consultant and the carrier, and how […]
The federal government plans to end much of the relief provided for under the original declaration of the COVID-19 National Emergency made on March 13, 2020. On May 4, 2020, […]
Please join us for a robust discussion addressing important issues and trends in the Fiduciary Liability marketplace. Three industry veterans will address and discuss current trends in the claims and […]
Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 […]
Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]
With a more diverse workforce, employers are receiving additional questions from employees regarding how Medicare enrollment interacts with, or otherwise affects, coverage under an employer-sponsored health benefit plan. In this session, we will explore the interaction between group health plans and Medicare and answer many of the questions employers/plan sponsors are asking about Medicare coverage, […]
Please join us for a robust discussion addressing important issues and trends involving the recent changes in Minnesota law regarding Marijuana. Two local attorneys will discuss the new legislation and its potential impact on Employers and Employees. REGISTER HERE DISCLAIMER: Brown & Brown, Inc. and all its affiliates, do not provide legal, regulatory or tax guidance, […]
